| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
82,270,000 |
| Market
Cap: |
248.46(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$3.16 - $32.51 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 8.1 |
| Insider 6 Months : 8.1 |
| Insider 3/6 Months : 16.7 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Revance Therapeutics is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. Co.'s segments are: Product, which refers to the business that includes the research, development and commercialization of its product candidates and the RHA® Collection of dermal fillers; and Service, which refers to the business that includes the development and commercialization of the OPUL™ Relational Commerce Platform and HintMD platform.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
30,000 |
30,000 |
30,000 |
30,000 |
| Total Buy Value |
$209,400 |
$209,400 |
$209,400 |
$209,400 |
| Total People Bought |
1 |
1 |
1 |
1 |
| Total Buy Transactions |
1 |
1 |
1 |
1 |
| Total Shares Sold |
29,089 |
29,089 |
157,681 |
446,160 |
| Total Sell Value |
$143,717 |
$143,717 |
$3,260,512 |
$12,719,522 |
| Total People Sold |
4 |
4 |
5 |
5 |
| Total Sell Transactions |
4 |
4 |
13 |
27 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ruegg Curtis |
EVP, Technical Operations |
• – – |
2015-05-18 |
4 |
OE |
$6.60 |
$16,500 |
D/D |
2,500 |
21,837 |
|
- |
|
| Ruegg Curtis |
EVP, Technical Operations |
• – – |
2015-05-15 |
4 |
AS |
$25.00 |
$12,500 |
D/D |
(500) |
19,337 |
|
- |
|
| Ruegg Curtis |
EVP, Technical Operations |
• – – |
2015-05-15 |
4 |
OE |
$6.60 |
$3,300 |
D/D |
500 |
19,837 |
|
- |
|
| Ruegg Curtis |
EVP, Technical Operations |
• – – |
2015-04-17 |
4 |
AS |
$22.23 |
$44,467 |
D/D |
(2,000) |
19,337 |
|
- |
|
| Ruegg Curtis |
EVP, Technical Operations |
• – – |
2015-04-17 |
4 |
OE |
$6.60 |
$13,200 |
D/D |
2,000 |
20,337 |
|
- |
|
| Ruegg Curtis |
EVP, Technical Operations |
• – – |
2015-03-19 |
4 |
AS |
$20.00 |
$10,000 |
D/D |
(500) |
19,337 |
|
- |
|
| Ruegg Curtis |
EVP, Technical Operations |
• – – |
2015-03-19 |
4 |
OE |
$6.60 |
$3,300 |
D/D |
500 |
19,837 |
|
- |
|
| Ruegg Curtis |
EVP, Technical Operations |
• – – |
2015-03-17 |
4 |
AS |
$18.61 |
$27,915 |
D/D |
(1,500) |
19,337 |
|
- |
|
| Ruegg Curtis |
EVP, Technical Operations |
• – – |
2015-03-17 |
4 |
OE |
$6.60 |
$9,900 |
D/D |
1,500 |
20,837 |
|
- |
|
| Ruegg Curtis |
EVP, Technical Operations |
• – – |
2015-03-09 |
4 |
AS |
$18.00 |
$9,000 |
D/D |
(500) |
19,337 |
|
- |
|
| Ruegg Curtis |
EVP, Technical Operations |
• – – |
2015-03-09 |
4 |
OE |
$6.60 |
$3,300 |
D/D |
500 |
19,837 |
|
- |
|
| Ruegg Curtis |
EVP, Technical Operations |
• – – |
2015-02-17 |
4 |
AS |
$16.80 |
$16,800 |
D/D |
(1,000) |
19,337 |
|
- |
|
| Ruegg Curtis |
EVP, Technical Operations |
• – – |
2015-02-17 |
4 |
OE |
$2.55 |
$5,912 |
D/D |
1,000 |
20,337 |
|
- |
|
| Waugh Jacob |
Chief Scientific Officer |
• – – |
2015-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
6,544 |
31,544 |
|
- |
|
| Ruegg Curtis |
EVP R&D and Tech Operations |
• – – |
2015-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
5,231 |
19,337 |
|
- |
|
| Silvernail Lauren P |
CFO, Secretary & EVP Corp Dev. |
• – – |
2015-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
7,290 |
23,270 |
|
- |
|
| Browne L Daniel |
CEO and President |
• • – |
2015-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
43,500 |
217,126 |
|
- |
|
| Bertolino Arthur Peter |
EVP and Chief Medical Officer |
• – – |
2015-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
6,078 |
45,453 |
|
- |
|
| Ruegg Curtis |
EVP R&D and Tech Operations |
• – – |
2015-01-20 |
4 |
AS |
$17.25 |
$17,250 |
D/D |
(1,000) |
14,106 |
|
- |
|
| Ruegg Curtis |
EVP R&D and Tech Operations |
• – – |
2015-01-20 |
4 |
OE |
$2.55 |
$2,550 |
D/D |
1,000 |
15,106 |
|
- |
|
| Ruegg Curtis |
EVP R&D and Tech Operations |
• – – |
2015-01-09 |
4 |
AS |
$18.00 |
$9,000 |
D/D |
(500) |
14,106 |
|
- |
|
| Ruegg Curtis |
EVP R&D and Tech Operations |
• – – |
2015-01-09 |
4 |
OE |
$2.55 |
$1,275 |
D/D |
500 |
14,606 |
|
- |
|
| Ruegg Curtis |
EVP R&D and Tech Operations |
• – – |
2014-12-17 |
4 |
AS |
$16.45 |
$16,450 |
D/D |
(1,000) |
14,106 |
|
- |
|
| Ruegg Curtis |
EVP R&D and Tech Operations |
• – – |
2014-12-17 |
4 |
OE |
$2.55 |
$2,550 |
D/D |
1,000 |
15,106 |
|
- |
|
| Silvernail Lauren P |
CFO, Secretary & EVP Corp Dev. |
• – – |
2014-12-11 |
4 |
B |
$17.73 |
$17,383 |
D/D |
980 |
14,980 |
2.74 |
- |
|
397 Records found
|
|
Page 15 of 16 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.14 (4.43%) 
